The Life Extension Foundation News reprints an interesting breakdown of the current set of drugs for age-related conditions in human trials or awaiting FDA approval. It gives a good view of research and regulatory priorities: "123 medicines would treat heart disease and stroke and 395 would assist cancer patients ... 22 new medications being developed against Alzheimer's ... 14 new drugs being developed for Parkinson's disease and 53 for diabetes. Eighteen of the proposed new compounds would treat osteoporosis." The cancer research establishment is enormous, the result of thirty years of deliberate intent, education and strong public support. This is a model we should emulate for the future of serious research into a cure for the aging process.